Bank of New York Mellon Corp grew its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 2.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,783,485 shares of the conglomerate's stock after purchasing an additional 194,466 shares during the quarter. Bank of New York Mellon Corp owned approximately 1.23% of Danaher worth $1,800,614,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. GHP Investment Advisors Inc. grew its position in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares during the last quarter. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $27,000. Smallwood Wealth Investment Management LLC acquired a new stake in shares of Danaher in the first quarter valued at approximately $31,000. Rialto Wealth Management LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $34,000. Finally, Hurley Capital LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $34,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on DHR shares. Citigroup restated a "buy" rating on shares of Danaher in a research report on Monday, April 7th. TD Cowen raised their target price on shares of Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a research report on Wednesday, April 23rd. Evercore ISI decreased their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research report on Tuesday. Wolfe Research decreased their target price on shares of Danaher from $275.00 to $220.00 and set an "outperform" rating on the stock in a research report on Monday, April 7th. Finally, Robert W. Baird decreased their target price on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Four equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $248.00.
Check Out Our Latest Stock Analysis on DHR
Insider Buying and Selling at Danaher
In other news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman directly owned 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president directly owned 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.20% of the stock is owned by company insiders.
Danaher Trading Up 0.5%
Shares of DHR stock traded up $1.07 during mid-day trading on Tuesday, reaching $200.70. The company's stock had a trading volume of 4,225,555 shares, compared to its average volume of 3,502,202. The company's 50 day simple moving average is $195.74 and its 200-day simple moving average is $206.85. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $143.63 billion, a PE ratio of 38.97, a price-to-earnings-growth ratio of 2.80 and a beta of 0.77.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 15.81% and a return on equity of 10.80%. On average, research analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.
Danaher Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.64%. Danaher's dividend payout ratio is currently 24.85%.
About Danaher
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More

Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.